Skip to main content
. 2021 Jun 16;43(1):928–933. doi: 10.1080/0886022X.2021.1936038

Table 1.

Clinical parameters of patient A and B before, during, and post FMT.

Patient A Before FMT Number of FMT (times)
Follow up (month)
20 40 55 65 75 87 97 1 3 6
24-h total urine protein (mg) 2605 2278 2237 1850 1517 1580 2249 1642 2116 1390 1000
eGFR (mL/min/1.73 m2) 51.0 49.9 42.9 51.6 54.5 59.3 64.9 57.9 52.7 49.4 48.4
Serum creatinine (umol/L) 106 108 123 105 100 93 86 95 103 109 111
Serum albumin (g/L) 32.8 34.6 39.5 31.7 37 37.2 36.6 40 42.7 41.7 43.5
Cystatin C (mg/L) 0.99 1.38 1.26 1.2 1.57 1.27 1.32 1.40 1.38 1.52 1.35
Patient B Before FMT Number of FMT (times)
Follow up (month)
10 20 30 40 50 60 1 3 6
24-h total urine protein (mg) 2744 1365 1368 1350 1178 1080 1020 1070 1629 1670
eGFR (mL/min/1.73 m2) 72.4 69.6 74.5 86.6 68.7 66.9 74.5 75.5 74.5 71.5
Serum creatinine (umol/L) 84 87 82 72 88 90 82 81 82 85
Serum albumin (g/L) 32.6 33.5 36.1 33.6 34.9 36.7 39 43.1 39.8 42.1
Cystatin C (mg/L) 1.18 1.20 1.13 1.06 1.02 1.21 1.24 1.23 1.18 1.09

FMT: fecal microbiota transplantation; eGFR: estimated glomerular filtration rate.